Misguiding Cues used by Viruses to Thwart Protective Immunity:
Lessons for Tumor Immunity
Ellis L. Reinherz MD, Professor of Medicine, Harvard Medical School; Director, Cancer Vaccine
Center and Chief, Laboratory of Immunobiology, Dana Farber Cancer Institute, USA
New Vaccine Technologies: A
Regulatory Perspective
Jon R. Daugherty, Ph.D., U.S. Public Health Service, Senior Regulatory
Review
Officer, Office of Vaccines Research and Review, CBER/FDA
Targeting Toll-Like Receptor 9 for Cancer Therapy
Arthur M. Krieg, M.D., Founder & Chief Scientific Officer, Coley Pharmaceutical Group Inc., USA
Exploit Inflammation to Induce Anti-Tumor Immunity: Old Weapons
and New Effector Mechanisms
Sven Brandau, Ph.D., Head, Division of Immunotherapy, Department of Immunology and Cell
Biology, Research Center Borstel, Germany |
